Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Osteosarcoma × mifamurtide × Clear all

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Ifosfamide 5 Doxorubicin 4 Methotrexate 3 Etoposide 3 Cisplatin 3 Specimen Handling 2 Sorafenib 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 sargramostim 1 pepinemab 1 peginterferon alfa-2b 1 mifamurtide 1 merphos 1 lorukafusp alfa 1 irinotecan sucrosofate 1 imetelstat 1 etoposide phosphate 1 Zoledronic Acid 1 X-Rays 1 Thrombopoietin 1 Thoracotomy 1 Thoracostomy 1 Thoracoscopy 1 Reverse Transcriptase Polymerase Chain Reaction 1 Razoxane 1 Radiosurgery 1 QL1206 1 Polymerase Chain Reaction 1 Platinum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01459484 2024-05-20

ISG/OS-2

Italian Sarcoma Group

Phase 2 Completed

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡